Cargando…
Short-course neoadjuvant in situ vaccination for murine melanoma
BACKGROUND: Surgical resection remains an important component of multimodality treatment for most solid tumors. Neoadjuvant immunotherapy has several potential advantages, including in-situ tumor vaccination and pathologic assessment of response in the surgical specimen. We previously described an i...
Autores principales: | Aiken, Taylor J, Komjathy, David, Rodriguez, Matthew, Stuckwisch, Ashley, Feils, Arika, Subbotin, Vladimir, Birstler, Jen, Gillies, Stephen D, Rakhmilevich, Alexander L, Erbe, Amy K, Sondel, Paul M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8765065/ https://www.ncbi.nlm.nih.gov/pubmed/35039460 http://dx.doi.org/10.1136/jitc-2021-003586 |
Ejemplares similares
-
Mechanism of effective combination radio-immunotherapy against 9464D-GD2, an immunologically cold murine neuroblastoma
por: Aiken, Taylor J, et al.
Publicado: (2022) -
Radiation to all macroscopic sites of tumor permits greater systemic antitumor response to in situ vaccination
por: Carlson, Peter M, et al.
Publicado: (2023) -
Neoadjuvant in situ vaccination with cowpea mosaic virus as a novel therapy against canine inflammatory mammary cancer
por: Alonso-Miguel, Daniel, et al.
Publicado: (2022) -
In situ vaccination with cowpea mosaic virus elicits systemic antitumor immunity and potentiates immune checkpoint blockade
por: Mao, Chenkai, et al.
Publicado: (2022) -
In situ immunization of a TLR9 agonist virus-like particle enhances anti-PD1 therapy
por: Cheng, Yinwen, et al.
Publicado: (2020)